What is Pfizer Inc?
Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical company founded in 1849 by two cousins, German American Charles (Karl) Pfizer and his German cousin Charles F Erhart. From its humble beginnings in chemical production, Pfizer has grown to become one of the largest pharmaceutical companies in the world. The company has its corporate headquarters in New York and is traded on the New York Stock Exchange.
Originally focused on chemical production, the company underwent a period of rapid expansion early on when it began to focus on the production of citric acid. The invention of a novel method of mass production of penicillin through a proprietary fermentation process during WWII cemented Pfizer’s place as one of the top pharmaceutical companies in the world. Following WWII, the company pursued a large number of acquisitions allowing for continuous growth. Its current product line-up includes household names such as Lipitor, Celebrex, and Viagra, as well as one of the earliest coronavirus vaccine candidates.
In present times, the company is engaged in the discovery, development and manufacture of healthcare products. The company is structured in the two key segments of Innovative Health and Essential Health. Innovative Health is focused on the development and commercialisation of medicines and vaccines in the therapeutic areas of internal medicine, vaccines, oncology, inflammation and immunity, rare diseases and consumer healthcare. The Essential Health division includes legacy and generic brands, sterile generic injectables, biosimilars and infusion systems.
Performance of Pfizer stock price
The Pfizer share price has remained relatively stable during the coronavirus pandemic of 2020. The Pfizer share price was supported by its activities in the development of a vaccine for the virus and, in late 2020, by the announcement that its leading candidate showed around a 95 per cent success rate in late-stage trials.
As of late 2020, the Pfizer share price has traded within the 52-week range of $27.88-$41.99 with a market cap of over $203bn (£152bn, €170bn). There have been five stock splits in the history of the company, starting in 1983, with the most recent being a 3:1 split in 1999. Pfizer stock trading has an average volume of 27 million shares per day.
How to invest in Pfizer stock
Pfizer stock trading occurs on the New York Stock Exchange. Those looking to invest in Pfizer stock can purchase them directly through the exchange or the company, via a broker, or indirectly through an index which includes PFE. Traders are also able to purchase derivatives based on PFE shares such as CFDs or options.
Traders looking to invest in Pfizer stock by using the Currency.com tokenised platform are able to profit from upward or downward movements in the Pfizer share price without having to invest directly. Tokenised assets are crypto derivatives whose value is linked to the value of a particular asset, in this case the Pfizer share price. The token is registered using distributed ledger technology (DLT) the same way cryptocurrency is recorded. This technology allows for trading using crypto without the need of converting back and forth with fiat currency, saving exchange fees. The utilisation of this technology allows for tokenised asset trading to be efficient, inexpensive and secure.
Trading tokenised assets based on the Pfizer stock price, you can take a long or short position depending on whether you feel the price today is over or under-valued based on the price chart. If you think the Pfizer stock price will decrease you can take a short position; if you think it will increase you can take a long position. Trading in tokenised assets on Currency.com also allows for traders to benefit from the leverage offered on the platform, up to 1:500.
Why trade tokensied Pfizer shares with Currency.com
Trading tokenised Pfizer shares at Currency.com tokenised assets exchange has a number of advantages. Tokens are underpinned by robust and immutable blockchain technology; opening a trade will give you a token that tracks and moves according to the underlying instrument’s price.
- One-stop crypto trading platform
Trade tokenised Pfizer shares with Bitcoin or Ethereum. Benefit from the shares price movements without exchanging your crypto assets into fiat.
Trade tokenised shares with a tight market spread, benefit from maker rebates and competitive taker fees.
Experienced traders can trade the world’s top stocks, like PFE, with up to 1:500 leverage.
- Effective risk management
Manage your risks and secure your profits with stop-loss and take-profit orders. Save your assets with negative balance protection.
We have a scalable and low latency order management system, which can execute 50 million trades per second.
Currency.com operates under new Belarusian regulation with best-in-class AML and KYC laws. Regulatory details and fees are upfront.
Tokenised share trading guide
Trading tokenised Pfizer shares is no more difficult than trading regular shares. To begin trading tokenised assets, you will follow need to follow some simple steps:
- 1. Register for an account with Currency.com.
- 2. Deposit funds (with crypto or fiat) in the account.
- 3. Determine the position size desired, accounting for leverage offered by Currency.com.
- 4. Determine your trading position (long or short) based on expected price movement and purchase tokenised Pfizer shares. Currency.com matches the long orders from its clients with the sell orders and then hedges the unmatched orders through Capital.com, LMAX Digital or exchanges such as Binance, Bitstamp, Kraken, Nasdaq, NYSE, and Gain Capital.
- 5. Close your position when applicable. You can set a take-profit or stop-loss indicator to ensure you are not required to constantly monitor the price. Funds will deposit back to your account after closing and you can withdraw or take a new position.